Cargando…
PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications
Brain ischemia/reperfusion (I/R) injury (BI/RI) is a leading cause of death and disability worldwide. However, the outcome of pharmacotherapy for BI/RI remains unsatisfactory. Innovative approaches for enhancing drug sensitivity and recovering neuronal activity in BI/RI treatment are urgently needed...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367577/ https://www.ncbi.nlm.nih.gov/pubmed/28356740 http://dx.doi.org/10.2147/IJN.S130842 |
_version_ | 1782517797858836480 |
---|---|
author | Xu, Guangtao Gu, Huan Hu, Bo Tong, Fei Liu, Daojun Yu, Xiaojun Zheng, Yongxia Gu, Jiang |
author_facet | Xu, Guangtao Gu, Huan Hu, Bo Tong, Fei Liu, Daojun Yu, Xiaojun Zheng, Yongxia Gu, Jiang |
author_sort | Xu, Guangtao |
collection | PubMed |
description | Brain ischemia/reperfusion (I/R) injury (BI/RI) is a leading cause of death and disability worldwide. However, the outcome of pharmacotherapy for BI/RI remains unsatisfactory. Innovative approaches for enhancing drug sensitivity and recovering neuronal activity in BI/RI treatment are urgently needed. The purpose of this study was to evaluate the protective effects of tumor necrosis factor (TNF)-α-loaded poly(ethylene glycol)-b-(poly(ethylenediamine L-glutamate)-g-poly(L-lysine)) (TNF-α/PEG-b-(PELG-g-PLL)) nanoparticles on BI/RI. The particle size of PEG-b-(PELG-g-PLL) and the loading and release rates of TNF-α were determined. The nanoparticle cytotoxicity was evaluated in vitro using rat cortical neurons. Sprague Dawley rats were preconditioned with free TNF-α or TNF-α/PEG-b-(PELG-g-PLL) polyplexes and then subjected to 2 hours ischemia and 22 hours reperfusion. Brain edema was assessed using the brain edema ratio, and the antioxidative activity was assessed by measuring the superoxide dismutase (SOD) activity and the malondialdehyde (MDA) content in the brain tissue. We further estimated the inflammatory activity and apoptosis level by determining the levels of interleukin-4 (IL-4), IL-6, IL-8, IL-10, and nitric oxide (NO), as well as the expression of glial fibrillary acidic protein (GFAP), intercellular adhesion molecule-1 (ICAM-1), and cysteine aspartase-3 (caspase-3), in the brain tissue. We provide evidence that TNF-α preconditioning attenuated the oxidative stress injury, the inflammatory activity, and the apoptosis level in I/R-induced cerebral injury, while the application of block copolymer PEG-b-(PELG-g-PLL) as a potential TNF-α nanocarrier with sustained release significantly enhanced the bioavailability of TNF-α. We propose that the block copolymer PEG-b-(PELG-g-PLL) may function as a potent nanocarrier for augmenting BI/RI pharmacotherapy, with unprecedented clinical benefits. Further studies are needed to better clarify the underlying mechanisms. |
format | Online Article Text |
id | pubmed-5367577 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-53675772017-03-29 PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications Xu, Guangtao Gu, Huan Hu, Bo Tong, Fei Liu, Daojun Yu, Xiaojun Zheng, Yongxia Gu, Jiang Int J Nanomedicine Original Research Brain ischemia/reperfusion (I/R) injury (BI/RI) is a leading cause of death and disability worldwide. However, the outcome of pharmacotherapy for BI/RI remains unsatisfactory. Innovative approaches for enhancing drug sensitivity and recovering neuronal activity in BI/RI treatment are urgently needed. The purpose of this study was to evaluate the protective effects of tumor necrosis factor (TNF)-α-loaded poly(ethylene glycol)-b-(poly(ethylenediamine L-glutamate)-g-poly(L-lysine)) (TNF-α/PEG-b-(PELG-g-PLL)) nanoparticles on BI/RI. The particle size of PEG-b-(PELG-g-PLL) and the loading and release rates of TNF-α were determined. The nanoparticle cytotoxicity was evaluated in vitro using rat cortical neurons. Sprague Dawley rats were preconditioned with free TNF-α or TNF-α/PEG-b-(PELG-g-PLL) polyplexes and then subjected to 2 hours ischemia and 22 hours reperfusion. Brain edema was assessed using the brain edema ratio, and the antioxidative activity was assessed by measuring the superoxide dismutase (SOD) activity and the malondialdehyde (MDA) content in the brain tissue. We further estimated the inflammatory activity and apoptosis level by determining the levels of interleukin-4 (IL-4), IL-6, IL-8, IL-10, and nitric oxide (NO), as well as the expression of glial fibrillary acidic protein (GFAP), intercellular adhesion molecule-1 (ICAM-1), and cysteine aspartase-3 (caspase-3), in the brain tissue. We provide evidence that TNF-α preconditioning attenuated the oxidative stress injury, the inflammatory activity, and the apoptosis level in I/R-induced cerebral injury, while the application of block copolymer PEG-b-(PELG-g-PLL) as a potential TNF-α nanocarrier with sustained release significantly enhanced the bioavailability of TNF-α. We propose that the block copolymer PEG-b-(PELG-g-PLL) may function as a potent nanocarrier for augmenting BI/RI pharmacotherapy, with unprecedented clinical benefits. Further studies are needed to better clarify the underlying mechanisms. Dove Medical Press 2017-03-23 /pmc/articles/PMC5367577/ /pubmed/28356740 http://dx.doi.org/10.2147/IJN.S130842 Text en © 2017 Xu et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Xu, Guangtao Gu, Huan Hu, Bo Tong, Fei Liu, Daojun Yu, Xiaojun Zheng, Yongxia Gu, Jiang PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications |
title | PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications |
title_full | PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications |
title_fullStr | PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications |
title_full_unstemmed | PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications |
title_short | PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications |
title_sort | peg-b-(pelg-g-pll) nanoparticles as tnf-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5367577/ https://www.ncbi.nlm.nih.gov/pubmed/28356740 http://dx.doi.org/10.2147/IJN.S130842 |
work_keys_str_mv | AT xuguangtao pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications AT guhuan pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications AT hubo pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications AT tongfei pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications AT liudaojun pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications AT yuxiaojun pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications AT zhengyongxia pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications AT gujiang pegbpelggpllnanoparticlesastnfananocarrierspotentialcerebralischemiareperfusioninjurytherapeuticapplications |